Dashboard
1
Poor Management Efficiency with a low ROCE of 1.41%
- The company has been able to generate a Return on Capital Employed (avg) of 1.41% signifying low profitability per unit of total capital (equity and debt)
2
Poor long term growth as Net Sales has grown by an annual rate of -16.74% and Operating profit at -154.36% over the last 5 years
3
Flat results in Sep 25
4
Risky -
5
Underperformed the market in the last 1 year
Stock DNA
Pharmaceuticals & Biotechnology
CNY 2,261 Million (Small Cap)
3,321.00
NA
1.48%
-0.22
0.24%
0.87
Revenue and Profits:
Net Sales:
213 Million
(Quarterly Results - Mar 2026)
Net Profit:
17 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
8.96%
0%
8.96%
6 Months
0.95%
0%
0.95%
1 Year
-0.8%
0%
-0.8%
2 Years
-16.06%
0%
-16.06%
3 Years
-9.18%
0%
-9.18%
4 Years
-18.28%
0%
-18.28%
5 Years
-19.08%
0%
-19.08%
Guangdong Vtr Bio-Tech Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
-16.74%
EBIT Growth (5y)
-154.36%
EBIT to Interest (avg)
-1.20
Debt to EBITDA (avg)
0.91
Net Debt to Equity (avg)
-0.26
Sales to Capital Employed (avg)
0.30
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
154.32%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
1.41%
ROE (avg)
2.03%
Valuation key factors
Factor
Value
P/E Ratio
3321
Industry P/E
Price to Book Value
1.28
EV to EBIT
-177.20
EV to EBITDA
24.98
EV to Capital Employed
1.37
EV to Sales
3.27
PEG Ratio
NA
Dividend Yield
1.01%
ROCE (Latest)
-0.77%
ROE (Latest)
0.04%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Sideways
Moving Averages
Mildly Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
No Trend
Mildly Bullish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ
Mar'26
Dec'25
Change(%)
Net Sales
212.60
219.10
-2.97%
Operating Profit (PBDIT) excl Other Income
14.20
-4.80
395.83%
Interest
0.00
0.00
Exceptional Items
3.70
-4.60
180.43%
Consolidate Net Profit
17.30
-38.00
145.53%
Operating Profit Margin (Excl OI)
66.80%
-172.20%
23.90%
USD in Million.
Net Sales
QoQ Growth in quarter ended Mar 2026 is -2.97% vs 10.60% in Dec 2025
Consolidated Net Profit
QoQ Growth in quarter ended Mar 2026 is 145.53% vs -875.51% in Dec 2025
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
827.90
823.20
0.57%
Operating Profit (PBDIT) excl Other Income
106.50
115.40
-7.71%
Interest
1.40
7.10
-80.28%
Exceptional Items
-5.00
5.20
-196.15%
Consolidate Net Profit
-18.50
32.00
-157.81%
Operating Profit Margin (Excl OI)
-28.90%
-1.40%
-2.75%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is 0.57% vs 4.77% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is -157.81% vs 2,566.67% in Dec 2024
About Guangdong Vtr Bio-Tech Co., Ltd. 
Guangdong Vtr Bio-Tech Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






